Literature DB >> 15937690

Alpha-chemokine receptors CXCR1-3 and their ligands in idiopathic inflammatory myopathies.

Boel De Paepe1, Kristel De Keyzer, Jean-Jacques Martin, Jan L De Bleecker.   

Abstract

The idiopathic inflammatory myopathies (IIM) are a heterogeneous group of neuromuscular disorders subdivided into polymyositis (PM), sporadic inclusion body myositis (sIBM) and dermatomyositis (DM). Chemokines play an essential role in sustained inflammation associated with IIM. We studied the distribution of the alpha-chemokine receptors CXCR1, 2, 3 and their ligands interferon-gamma (IFN-gamma)-inducible T cell alpha chemoattractant (I-TAC), IFN-gamma-inducible protein of 10 kDa (IP-10), monokine induced by IFN-gamma (MIG) and growth-related oncogene (GRO) in IIM using immunohistochemistry, immunofluorescence and Western blotting. Abundant expression of IP-10 was observed on macrophages and T cells surrounding and invading non-necrotic muscle fibers in PM and sIBM and in T cells in perimysial infiltrates of DM. IP-10 was also localized to blood vessel endothelial cells in all inflammatory and normal muscle tissues. The distribution of other alpha-chemokines was variable: Only low levels of MIG and I-TAC were detected; GRO was localized to the endomysial infiltrates of some PM and sIBM samples, but not in DM. Muscle tissues were invariably CXCR1 negative, while a subset of inflammatory cells in all IIM were CXCR2 positive. Strong CXCR3 expression was observed on the majority of T cells in each IIM. We describe the differential repertoire of alpha-chemokines in IIM, and offer additional proof of the predominance of Th1-driven reactions in the immunopathogenesis of all three diagnostic subgroups. We suggest the Th1-mediated immunity in general, and the CXCR3/IP-10 interaction in particular, as potential targets for novel therapeutic intervention in IIM.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15937690     DOI: 10.1007/s00401-005-0989-5

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  17 in total

Review 1.  Dermatomyositis.

Authors:  M S Krathen; D Fiorentino; V P Werth
Journal:  Curr Dir Autoimmun       Date:  2008

2.  Severe dermatomyositis triggered by interferon beta-1a therapy and associated with enhanced type I interferon signaling.

Authors:  Ally-Khan Somani; Alan R Swick; Kevin D Cooper; Thomas S McCormick
Journal:  Arch Dermatol       Date:  2008-10

3.  [New aspects on the pathogenesis of myositis].

Authors:  B Stuhlmüller; E Feist; T Häupl; G-R Burmester; N Pipitone
Journal:  Z Rheumatol       Date:  2013-04       Impact factor: 1.372

Review 4.  The tumor necrosis factor superfamily of cytokines in the inflammatory myopathies: potential targets for therapy.

Authors:  Boel De Paepe; Kim K Creus; Jan L De Bleecker
Journal:  Clin Dev Immunol       Date:  2011-10-23

Review 5.  Scanning for Therapeutic Targets within the Cytokine Network of Idiopathic Inflammatory Myopathies.

Authors:  Boel De Paepe; Jana Zschüntzsch
Journal:  Int J Mol Sci       Date:  2015-08-11       Impact factor: 5.923

6.  Sarcoidosis: Is It a Possible Trigger of Inclusion Body Myositis?

Authors:  Ali Zakaria; Issam Turk; Kenneth Leung; Ana Capatina-Rata; Waseem Farra
Journal:  Case Rep Rheumatol       Date:  2017-04-24

Review 7.  Immune and myodegenerative pathomechanisms in inclusion body myositis.

Authors:  Christian W Keller; Jens Schmidt; Jan D Lünemann
Journal:  Ann Clin Transl Neurol       Date:  2017-05-16       Impact factor: 4.511

8.  Th1 response and systemic treg deficiency in inclusion body myositis.

Authors:  Yves Allenbach; Wahiba Chaara; Michelle Rosenzwajg; Adrien Six; Nicolas Prevel; Federico Mingozzi; Julia Wanschitz; Lucile Musset; Jean-Luc Charuel; Bruno Eymard; Benoit Salomon; Charles Duyckaerts; Thierry Maisonobe; Odile Dubourg; Serge Herson; David Klatzmann; Olivier Benveniste
Journal:  PLoS One       Date:  2014-03-04       Impact factor: 3.240

9.  Therapeutic effect of anti-C-X-C motif chemokine 10 (CXCL10) antibody on C protein-induced myositis mouse.

Authors:  Jinhyun Kim; Ji Yong Choi; Sung-Hye Park; Seung Hee Yang; Ji Ah Park; Kichul Shin; Eun Young Lee; Hiroshi Kawachi; Hitoshi Kohsaka; Yeong Wook Song
Journal:  Arthritis Res Ther       Date:  2014-06-17       Impact factor: 5.156

10.  Skeletal Muscle Inflammation Following Repeated Bouts of Lengthening Contractions in Humans.

Authors:  Michael R Deyhle; Amanda M Gier; Kaitlyn C Evans; Dennis L Eggett; W Bradley Nelson; Allen C Parcell; Robert D Hyldahl
Journal:  Front Physiol       Date:  2016-01-12       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.